Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)

2021-02-12T00:14:15-08:00August 9th, 2017|2017 Publications, Publications|